Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RFP
1276
DELISTED
Resolute Forest Products Inc.
RFP
| $7.21M | 0.01% |
333,800
-43,200
| -11% | -$904K |
|
1277
Puma Biotechnology
PBYI
$444M
| $7.19M | 0.01% |
1,698,843
-100,819
| -6% | -$348K |
|
1278
Darling Ingredients
DAR
$10.6B
| $7.18M | 0.01% |
114,675
+109,375
| +2,064% | +$7.71M |
|
|
ESSA
1279
DELISTED
ESSA Bancorp
ESSA
| $7.17M | 0.01% |
343,775
-18,743
| -5% | -$381K |
|
1280
Entegris
ENTG
$24.5B
| $7.17M | 0.01% |
109,310
+45,440
| +71% | +$3.35M |
|
1281
Brixmor Property Group
BRX
$9.24B
| $7.16M | 0.01% |
315,600
+98,900
| +46% | +$2.12M |
|
1282
Sun Life Financial
SLF
$45.1B
| $7.15M | 0.01% |
154,100
-126,500
| -45% | -$5.6M |
|
1283
Aurinia Pharmaceuticals
AUPH
$2.04B
| $7.14M | 0.01% |
1,653,200
+919,400
| +125% | +$5.33M |
|
1284
Fortuna Silver Mines
FSM
$3.15B
| $7.14M | 0.01% |
1,904,100
-1,696,471
| -47% | -$5.6M |
|
1285
Mercer International
MERC
$32.2M
| $7.14M | 0.01% |
613,300
+1,600
| +0.3% | +$21.3K |
|
1286
Knowles
KN
$3.28B
| $7.13M | 0.01% |
434,500
-9,500
| -2% | -$138K |
|
1287
Monro
MNRO
$358M
| $7.13M | 0.01% |
157,779
+75,000
| +91% | +$3.46M |
|
1288
Phibro Animal Health
PAHC
$1.4B
| $7.13M | 0.01% |
531,700
-9,800
| -2% | -$131K |
|
1289
Textron
TXT
$15.3B
| $7.13M | 0.01% |
100,700
+93,200
| +1,243% | +$6.33M |
|
1290
Kinetik
KNTK
$4.27B
| $7.11M | 0.01% |
215,062
-19,900
| -8% | -$678K |
|
1291
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $7.1M | 0.01% |
152,000
+99,000
| +187% | +$4.5M |
|
1292
Bassett Furniture
BSET
$167M
| $7.08M | 0.01% |
407,661
+200
| +0% | +$3.55K |
|
1293
Financial Institutions
FISI
$826M
| $7.08M | 0.01% |
290,800
-12,500
| -4% | -$307K |
|
|
AQUA
1294
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $7.07M | 0.01% |
178,600
+7,700
| +5% | +$303K |
|
1295
iShares California Muni Bond ETF
CMF
$4.62B
| $7.06M | 0.01% |
+125,800
| New | +$6.98M |
|
1296
G. Willi-Food International
WILC
$394M
| $7.06M | 0.01% |
536,252
-18,400
| -3% | -$260K |
|
1297
Avnet
AVT
$7.82B
| $7.02M | 0.01% |
168,800
-91,980
| -35% | -$3.82M |
|
1298
Ball Corp
BALL
$16.4B
| $7.01M | 0.01% |
+137,001
| New | +$7.09M |
|
1299
Methanex
MEOH
$4.31B
| $7M | 0.01% |
184,748
-70,802
| -28% | -$2.6M |
|
1300
Boyd Gaming
BYD
$6.09B
| $6.94M | 0.01% |
+127,300
| New | +$7.17M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.